Trusted Partner: Navigating Through All the Complexity of Deal-Making With China in Life Sciences
About MyBio Capital
MyBio Capital is a cross-border investment & advisory firm in the life sciences sector, with a team of 20+ professionals in China, US and Europe. Our mission is to bring global innovation to China. We are a trusted partner for companies seeking advice on China market entry, in/out-licensing, joint venture, and M&A.
Insights
2021 Annual Report on BD Deals in China Pharmaceutical Industry
The Enlightment of US 505(b)(2) to China’s Modified New Drug Policy
Global Orthopedic Implant Device Industry Investment Trend Report
Global Nanotechnology in Medical Applications Market
Clients
